MedTrace Logo

Exercise to Improve Sleep in Parkinson's Disease

NCT05644327 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-03-13

No results posted yet for this study

Summary

This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT), resistance training (RT), multimodal training (MT), or will be allocated to a control condition (i.e., waiting list - CON) for 12 weeks. Training will be performed three times/week. The assessments will be conducted at baseline, post-intervention, and follow-up (i.e. 8 weeks after the intervention) by assessors blinded to the participants' group allocation.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

Cardiovascular training (CT)

12 weeks of CT

BEHAVIORAL

Resistance training (RT)

12 weeks of RT

BEHAVIORAL

Multimodal training (MT)

12 weeks of MT

Sponsors & Collaborators

  • Jewish Rehabilitation Hospital

    collaborator OTHER

  • The Memory Lab

    collaborator UNKNOWN

  • The Human Brain Control of Locomotion Lab (HBCL)

    collaborator UNKNOWN

  • The Cummings Centre

    collaborator UNKNOWN

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • McGill University

    lead OTHER

Principal Investigators

  • Marc Roig, Ph.D. · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2027-12-30
Completion
2027-12-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05644327 on ClinicalTrials.gov